Perfinity Biosciences, Inc.
High-throughput consumable kits and automated instruments for laboratory workflow reproducibility and speed
- Sector
- Biotech
- Headquarters
- WEST LAFAYETTE, IN
- Founded
- 2010
- Latest Form D
- $2.3M, Jun 2010
- Total capital
- $5.3M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $4.7M
- 2 Form D · last Jun 2010
- 196 months since last filing
- Federal contracts
- $649K
- 12 awards · Health and Human S
- Rank in Biotech#214 of 4373
- Granted patents
- 2
- 9 pending · first 2019
- Rank in peer group#4 of 28
Capital timeline
Latest events
- Federal contractHealth and Human S · Trypsin Columns$80K
- Federal contractHealth and Human S · Trypsin Columns$120K
- Federal contractHealth and Human S · Pruchase Of Perfinity Trypspin Columns$32K
- Federal contractHealth and Human S · Immobilized Trypsin Columns$40K
- Federal contractHealth and Human S · Purchase Of Perfinity Tryspin Columns$42K
- Federal contractHealth and Human S · Igf::ot::igf For Other Functions - Purchase Of Parks Perfinity Tryspin Columns$40K
- Federal contractHealth and Human S · Labs Supplies$40K
- Private capital raisedForm D · SEC · 2nd filing$2.3M
- Private capital raisedForm D · SEC · 1st filing$2.3M
Show 5 earlier federal awards
- Federal contractHealth and Human S · Trypsin Columns And Kits$35K
- Federal contractHealth and Human S · Laboratory Equipment$7K
- Federal contractHealth and Human S · Perfinity Columns$34K
- Federal contractHealth and Human S · Profinity Trypsin Workstation Columns For Apolioprotein Digestion Effort$31K
- Federal contractHealth and Human S · SBIR Topic 238, Highest Sensitivity Cancer Marker Array On Quadraspec's Bio-cd Platform$148K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
32months
from Perfinity Biosciences, Inc.’s first federal award to its first private round.
- First federal award · Sep 2007
- Health and Human S · $148K
- First Form D · May 2010
- $2.3M · 1st Form D
- Awards before first raise
- 1 award
An association in public records, not a cause or a prediction.
Standing among 28 peers
Line = medianBiotech · System
- Granted patents#4 · top 14%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Drew F. PeyronninDirectorNamed in SEC Form D filings
- Frank P. ChengDirectorNamed in SEC Form D filings
- Fred F. RegnierDirectorNamed in SEC Form D filings
- Michael A. EvansDirectorNamed in SEC Form D filings
- R. Matthew NeffDirectorNamed in SEC Form D filings
- Stephen P. HokansonExecutive Officer, DirectorNamed in SEC Form D filings
Show all 8 people
- Steven PlumpExecutive OfficerNamed in SEC Form D filings
- Timothy R. FransonDirectorNamed in SEC Form D filings
What it has protected
USPTO · 2 granted of 11- GrantedA Single Reactor For Simplified Sample Preparation WorkflowsUSPTOUS 10,551,358
- GrantedRobust, Easy To Use Immobilized Enzyme ReactorsUSPTOUS 10,266,819
- PendingAutomated Protein Digestion, Recovery, And AnalysisUSPTOApplication 14396272
Show all 11 patent records
- A Single Reactor For Simplified Sample Preparation WorkflowsFeb 4, 2020 · US 10,551,358Granted
- Robust, Easy To Use Immobilized Enzyme ReactorsApr 23, 2019 · US 10,266,819Granted
- Automated Protein Digestion, Recovery, And AnalysisMay 21, 2015 · Application 14396272Pending
- Selector Based Recognition And Quantification System And Method For Multiple Analytes In A Single AnalysisApr 16, 2015 · Application 14378284Pending
- Enzyme Reactor System Enabling Enhanced Enzymatic Digestion And Improved Mass Spectrometric CompatibilityApplication 62069780Pending
- A Single Reactor For Simplified Sample Preparation WorkflowsApplication PCTUS2014067976Pending
- Robust Methods For The Prevention Of Protein Agglomeration During Enzymatic DigestionsApplication 62025783Pending
- Automated Protein Digestion, Recovery And AnalysisApplication PCTUS2013036781Pending
- Selector Based Recognition And Quantification System And Method For Multiple Analytes In A Single AnalysisApplication PCTUS2013023727Pending
- Enzyme Reactor System Enabling Enhanced Enzymatic Digestion, Analyte Solubility And Improved Mass Spectrometric CompatibilityApplication PCTUS2014066972Pending
- Affinity Selector Based Recognition And Quantification System And Method For Multiple Analytes In A Single AnalysisApplication PCTUS2010026819Pending
Related companies, and why
- KromaTiD, Inc.Similar federal contract value in Biotech · $726K in contracts
- APHIOS CORPORATIONSimilar federal contract value in Biotech · $723K in contracts
- PREDICTIVE BIOLOGYSimilar federal contract value in Biotech · $654K in contracts
- iXpressGenes, Inc.Similar federal contract value in Biotech · $614K in contracts
- NEUCYTE INCSimilar federal contract value in Biotech · $602K in contracts
- TEICHOS LABORATORIES, LLCSimilar federal contract value in Biotech · $600K in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .